Werewolf Therapeutics Stock Technical Analysis
| HOWL Stock | USD 1.33 0.01 0.75% |
As of the 18th of January 2025, Werewolf Therapeutics maintains the Standard Deviation of 7.43, market risk adjusted performance of (0.54), and Mean Deviation of 4.43. Werewolf Therapeutics technical analysis makes it possible for you to employ past prices and volume data with the intention to determine a pattern that calculates the direction of the company's future prices. Please check out Werewolf Therapeutics market risk adjusted performance, information ratio, as well as the relationship between the Information Ratio and skewness to decide if Werewolf Therapeutics is priced fairly, providing market reflects its latest price of 1.33 per share. Given that Werewolf Therapeutics is a hitting penny stock territory we urge to closely look at its jensen alpha.
Werewolf Therapeutics Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Werewolf, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to WerewolfWerewolf |
Werewolf Therapeutics Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 12.0 | Strong Buy | 6 | Odds |
Most Werewolf analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Werewolf stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Werewolf Therapeutics, talking to its executives and customers, or listening to Werewolf conference calls.
Werewolf Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Werewolf Therapeutics Technical Analysis
The output start index for this execution was one with a total number of output elements of sixty. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Werewolf Therapeutics volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Werewolf Therapeutics Trend Analysis
Use this graph to draw trend lines for Werewolf Therapeutics. You can use it to identify possible trend reversals for Werewolf Therapeutics as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Werewolf Therapeutics price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Werewolf Therapeutics Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Werewolf Therapeutics applied against its price change over selected period. The best fit line has a slop of 0.03 , which may suggest that Werewolf Therapeutics market price will keep on failing further. It has 122 observation points and a regression sum of squares at 25.02, which is the sum of squared deviations for the predicted Werewolf Therapeutics price change compared to its average price change.About Werewolf Therapeutics Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Werewolf Therapeutics on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Werewolf Therapeutics based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Werewolf Therapeutics price pattern first instead of the macroeconomic environment surrounding Werewolf Therapeutics. By analyzing Werewolf Therapeutics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Werewolf Therapeutics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Werewolf Therapeutics specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2024 | 2025 (projected) | Payables Turnover | 26.21 | 27.52 | Days Of Inventory On Hand | 2.62E-4 | 2.33E-4 |
Werewolf Therapeutics January 18, 2025 Technical Indicators
Most technical analysis of Werewolf help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Werewolf from various momentum indicators to cycle indicators. When you analyze Werewolf charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.03) | |||
| Market Risk Adjusted Performance | (0.54) | |||
| Mean Deviation | 4.43 | |||
| Coefficient Of Variation | (2,155) | |||
| Standard Deviation | 7.43 | |||
| Variance | 55.2 | |||
| Information Ratio | (0.05) | |||
| Jensen Alpha | (0.37) | |||
| Total Risk Alpha | (0.53) | |||
| Treynor Ratio | (0.55) | |||
| Maximum Drawdown | 49.02 | |||
| Value At Risk | (8.29) | |||
| Potential Upside | 7.96 | |||
| Skewness | 3.08 | |||
| Kurtosis | 13.79 |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Werewolf Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing. For more information on how to buy Werewolf Stock please use our How to buy in Werewolf Stock guide.You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Werewolf Therapeutics. If investors know Werewolf will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Werewolf Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.51) | Revenue Per Share | Quarterly Revenue Growth (0.86) | Return On Assets | Return On Equity |
The market value of Werewolf Therapeutics is measured differently than its book value, which is the value of Werewolf that is recorded on the company's balance sheet. Investors also form their own opinion of Werewolf Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Werewolf Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Werewolf Therapeutics' market value can be influenced by many factors that don't directly affect Werewolf Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Werewolf Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Werewolf Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Werewolf Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.